#USA #New York #Class Action #Securities Fraud #Park Ha

Pomerantz Law Firm's Class Action Alert on Park Ha Biological Technology Co., Ltd.

The Pomerantz Law Firm has recently made an important announcement for investors involved with Park Ha Biological Technology Co., Ltd. This company is currently facing a class action lawsuit that raises significant concerns related to securities fraud and unlawful business practices. Investors who have incurred losses on their investments in Park Ha are encouraged to take action swiftly.

Background of the Case

Pomerantz LLP has confirmed that the lawsuit filed against Park Ha is rooted in allegations of a manipulated stock market environment. More specifically, it is claimed that the company engaged in a “pump-and-dump” scheme, which allegedly involved misinformation spread via social media platforms. This public complaint outlines a concerning pattern where individuals impersonating financial experts promoted Park Ha's stock to induce a buying frenzy among inexperienced investors. This led to an artificially inflated stock price, raising serious questions about the legitimacy of the company's business operations.

On July 7, 2025, following a dramatic rise in stock value from an initial public offering price of $4.00 to a peak of $41.49, many investors began to feel the repercussions of these dubious promotional efforts. The absence of any corresponding positive developments in the company's corporate status further exacerbates the situation. Investigations have suggested that the drastic increase in stock price was unfounded, undermining investor confidence and leading to subsequent losses when stock values plummeted.

Important Deadlines and Actions

Investors who purchased or acquired securities during the class period should be aware that they have until September 28, 2026, to petition the court for appointment as Lead Plaintiff in this class action. Those interested can reach out to Danielle Peyton from the Pomerantz Law Firm either through email or by phone. It's crucial for investors to include their contact details and the total number of shares they bought when making inquiries.

Obtaining a copy of the lawsuit complaint is essential for those affected, and it can be accessed through the law firm’s official website. Given the seriousness of these allegations, it is imperative that investors stay informed about their rights and the legal recourse available to them.

About Pomerantz LLP

Established over 85 years ago, Pomerantz LLP is renowned for its expertise in corporate, securities, and antitrust class action litigation. Founded by Abraham L. Pomerantz, who was instrumental in developing the class action mechanism, the firm continues to uphold its mission of championing the rights of investors who have suffered due to fraudulent corporate practices. With a strong track record of securing multimillion-dollar settlements for clients, Pomerantz remains a trusted legal partner for those seeking justice in the turbulent waters of securities investing.

In conclusion, investors in Park Ha Biological Technology Co., Ltd. must act quickly if they wish to claim their rights in light of the ongoing class action. By doing so, they can join other shareholders striving for accountability in a case that illustrates the challenges within the current financial landscape.